Jan Sjöberg

2.0k total citations
45 papers, 1.4k citations indexed

About

Jan Sjöberg is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Jan Sjöberg has authored 45 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 17 papers in Immunology. Recurrent topics in Jan Sjöberg's work include Lymphoma Diagnosis and Treatment (17 papers), Immune Cell Function and Interaction (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Jan Sjöberg is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), Immune Cell Function and Interaction (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Jan Sjöberg collaborates with scholars based in Sweden, United Kingdom and United States. Jan Sjöberg's co-authors include Magnus Björkholm, Pavel Pisa, Dawei Xu, Hans‐Erik Claesson, Ola Landgren, Max Petersson, S. Horiguchi, Rolf Kiessling, Koji Kono and Ken Wasserman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jan Sjöberg

43 papers receiving 1.4k citations

Peers

Jan Sjöberg
Natasha M. Savage United States
Kenneth S. Zuckerman United States
A Tobler Switzerland
Nunzia Montuori Italy
Hirohiko Shibayama Japan
Ebrahim Sakhinia Iran
Makiko Kawaguchi Japan
Christina Halsey United Kingdom
Sachiko Ezoe Japan
Tomohisa Baba Japan
Natasha M. Savage United States
Jan Sjöberg
Citations per year, relative to Jan Sjöberg Jan Sjöberg (= 1×) peers Natasha M. Savage

Countries citing papers authored by Jan Sjöberg

Since Specialization
Citations

This map shows the geographic impact of Jan Sjöberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Sjöberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Sjöberg more than expected).

Fields of papers citing papers by Jan Sjöberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Sjöberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Sjöberg. The network helps show where Jan Sjöberg may publish in the future.

Co-authorship network of co-authors of Jan Sjöberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Sjöberg. A scholar is included among the top collaborators of Jan Sjöberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Sjöberg. Jan Sjöberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moscetti, Luca, Paula B. van Hennik, B. Bolstad, et al.. (2020). Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects. ESMO Open. 5(4). e000856–e000856. 1 indexed citations
2.
Olsen, Thale Kristin, A. Ali Zirakzadeh, Louise K. Sjöholm, et al.. (2020). Hodgkin Lymphoma Monozygotic Triplets Reveal Divergences in DNA Methylation Signatures. Frontiers in Oncology. 10. 598872–598872. 2 indexed citations
3.
Tzogani, Kyriaki, Paula B. van Hennik, Jan Sjöberg, et al.. (2017). EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma. The Oncologist. 23(5). 631–636. 31 indexed citations
4.
Stanel, Stefan, Jan Sjöberg, Tomas Salmonson, et al.. (2017). European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer. ESMO Open. 2(2). e000190–e000190. 14 indexed citations
5.
Han, Hongya, Xinyan Miao, Edit Nagy, et al.. (2015). Early growth response gene (EGR)-1 regulates leukotriene D4-induced cytokine transcription in Hodgkin lymphoma cells. Prostaglandins & Other Lipid Mediators. 121(Pt A). 122–130. 4 indexed citations
6.
Holm, Göran, Margareta Andersson, Monica Ekberg, et al.. (2014). Setae from Larvae of the Northern Processionary Moth (Thaumetopoea pinivora, TP) Stimulate Proliferation of Human Blood Lymphocytes In Vitro. PLoS ONE. 9(12). e113977–e113977. 4 indexed citations
7.
Björkholm, Magnus, Erik Svedmyr, & Jan Sjöberg. (2011). How we treat elderly patients with Hodgkin lymphoma. Current Opinion in Oncology. 23(5). 421–428. 21 indexed citations
8.
Andersson, Erik, Frida Schain, Jan Sjöberg, Magnus Björkholm, & Hans‐Erik Claesson. (2009). Interleukin-13 stimulation of the mediastinal B-cell lymphoma cell line Karpas-1106P induces a phenotype resembling the Hodgkin lymphoma cell line L1236. Experimental Hematology. 38(2). 116–123. 13 indexed citations
9.
Schain, Frida, Anna Porwit, Dawei Xu, et al.. (2008). Differential Expression of Cysteinyl Leukotriene Receptor 1 and 15-Lipoxygenase-1 in Non-Hodgkin Lymphomas. Clinical Lymphoma & Myeloma. 8(6). 340–347. 11 indexed citations
10.
Schain, Frida, Ylva Tryselius, Jan Sjöberg, et al.. (2008). Evidence for a pathophysiological role of cysteinyl leukotrienes in classical Hodgkin lymphoma. International Journal of Cancer. 123(10). 2285–2293. 12 indexed citations
11.
Landgren, Ola, Magnus Björkholm, Scott Montgomery, et al.. (2005). Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-onset Hodgkin lymphoma. International Journal of Cancer. 118(2). 449–452. 7 indexed citations
12.
Liu, Cheng, Dawei Xu, Jan Sjöberg, et al.. (2004). Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Experimental Cell Research. 297(1). 61–67. 55 indexed citations
13.
Sjöberg, Jan, Margareta Andersson, Carlos García, et al.. (2002). Expression of the signal transduction molecule ζ in peripheral and tumour‐associated lymphocytes in Hodgkin's disease in relation to the Epstein–Barr virus status of the tumour cells. British Journal of Haematology. 116(4). 765–773. 1 indexed citations
14.
Axdorph, Ulla, Anna Porwit‐MacDonald, Jan Sjöberg, Gunnar Grimfors, & Magnus Björkholm. (2002). T‐cell‐rich B‐cell lymphoma – diagnostic and therapeutic aspects. Apmis. 110(5). 379–390. 12 indexed citations
15.
Axdorph, Ulla, Jan Sjöberg, Gunnar Grimfors, et al.. (2000). Biological markers may add to prediction of outcome achieved by the international prognostic score in Hodgkin's disease. Annals of Oncology. 11(11). 1405–1411. 41 indexed citations
16.
Kiessling, Rolf, Ken Wasserman, S. Horiguchi, et al.. (1999). Tumor-induced immune dysfunction. Cancer Immunology Immunotherapy. 48(7). 353–362. 194 indexed citations
17.
Sjöberg, Jan, et al.. (1999). Tumour necrosis factor‐α cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia. British Journal of Haematology. 104(2). 346–349. 31 indexed citations
18.
Axdorph, Ulla, Anna Porwit‐MacDonald, Jan Sjöberg, et al.. (1999). Epstein–Barr virus expression in Hodgkin’s disease in relation to patient characteristics, serum factors and blood lymphocyte function. British Journal of Cancer. 81(7). 1182–1187. 40 indexed citations
19.
Sjöberg, Jan, Eva K. Pisa, Å. Ljungdahl, et al.. (1996). Interleukin‐10 mRNA expression in B‐cell chronic lymphocytic leukaemia inversely correlates with progression of disease. British Journal of Haematology. 92(2). 393–400. 31 indexed citations
20.
Böttcher, Gerhard, Jan Sjöberg, Rolf Ekman, R. Håkanson, & F. Sundler. (1993). Peptide YY in the mammalian pancreas: immunocytochemical localization and immunochemical characterization. Regulatory Peptides. 43(3). 115–130. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natasha M. Savage Breakdown of academic impact, for papers by Kenneth S. Zuckerman Breakdown of academic impact, for papers by A Tobler Breakdown of academic impact, for papers by Nunzia Montuori Breakdown of academic impact, for papers by Hirohiko Shibayama Breakdown of academic impact, for papers by Ebrahim Sakhinia Breakdown of academic impact, for papers by Makiko Kawaguchi Breakdown of academic impact, for papers by Christina Halsey Breakdown of academic impact, for papers by Sachiko Ezoe Breakdown of academic impact, for papers by Tomohisa Baba
Rankless by CCL
2026